Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity
- 2 May 2003
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 10 (5) , 592-598
- https://doi.org/10.1038/sj.cdd.4401210
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Chronic myelogenous leukemiaCurrent Opinion in Oncology, 2001
- STAT5-Dependent CyclinD1 and Bcl-xL Expression in Bcr-Abl-Transformed CellsMolecular Cell Biology Research Communications, 2000
- Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xLOncogene, 1998
- Structural and Signaling Requirements for BCR-ABL-Mediated Transformation and Inhibition of ApoptosisMolecular and Cellular Biology, 1995
- Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogeneCell, 1995
- Differential Complementation of Bcr-Abl Point Mutants with c-MycScience, 1994
- A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins.Molecular and Cellular Biology, 1993
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990
- Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.Molecular and Cellular Biology, 1989
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972